Vimarsana
Biggest News Aggregation in the World

Page 4 - Nasdaq Bcab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Bcab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Bcab Today - Breaking & Trending Today

BioAtla (BCAB) Set to Announce Earnings on Tuesday - Vimarsana News

BioAtla (BCAB) Set to Announce Earnings on Tuesday

BioAtla (NASDAQ:BCAB – Get Rating) will be releasing its earnings data on Tuesday, May 2nd. BioAtla Stock Down 2.3 % Shares of BCAB opened at $3.37 on Monday. The company has a market capitalization of $160.45 million, a P/E ratio of -1.23 and a beta of 0.23. The firm has a 50 day moving average […]

Insider Buying: BioAtla, Inc. (NASDAQ:BCAB) Insider Acquires $48,000.00 in Stock - Vimarsana News

Insider Buying: BioAtla, Inc. (NASDAQ:BCAB) Insider Acquires $48,000.00 in Stock

BioAtla, Inc. (NASDAQ:BCAB – Get Rating) insider Christian Vasquez acquired 20,000 shares of the firm’s stock in a transaction on Tuesday, March 28th. The shares were acquired at an average price of $2.40 per share, with a total value of $48,000.00. Following the completion of the purchase, the insider now owns 102,709 shares in the […]

Source: wkrb13.com
BioAtla, Inc. (NASDAQ:BCAB) Insider Christian Vasquez Buys 20,000 Shares - Vimarsana News

BioAtla, Inc. (NASDAQ:BCAB) Insider Christian Vasquez Buys 20,000 Shares

BioAtla, Inc. (NASDAQ:BCAB – Get Rating) insider Christian Vasquez bought 20,000 shares of BioAtla stock in a transaction that occurred on Tuesday, March 28th. The shares were acquired at an average price of $2.40 per share, with a total value of $48,000.00. Following the completion of the transaction, the insider now owns 102,709 shares of […]

BioAtla (NASDAQ:BCAB) Price Target Cut to $13.00 - Vimarsana News

BioAtla (NASDAQ:BCAB) Price Target Cut to $13.00

BioAtla (NASDAQ:BCAB – Get Rating) had its price target reduced by analysts at BTIG Research to $13.00 in a research note issued to investors on Tuesday, The Fly reports. The firm currently has a “buy” rating on the stock. BTIG Research’s price target indicates a potential upside of 417.93% from the stock’s previous close. A […]

BioAtla (NASDAQ:BCAB) PT Lowered to $17.00 at HC Wainwright - Vimarsana News

BioAtla (NASDAQ:BCAB) PT Lowered to $17.00 at HC Wainwright

BioAtla (NASDAQ:BCAB – Get Rating) had its price target cut by HC Wainwright from $20.00 to $17.00 in a research report sent to investors on Friday morning, The Fly reports. They currently have a buy rating on the stock. Separately, EF Hutton Acquisition Co. I assumed coverage on shares of BioAtla in a report on […]

Source: wkrb13.com